Trials / Completed
CompletedNCT01199588
A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers
A Randomized, Parallel Group, Dose-Ranging, Controlled, Multi-Center Study to Assess the Efficacy and Safety of Nexagon® in the Treatment of Subjects With a Venous Leg Ulcer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- OcuNexus Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is for subjects with a venous leg ulcer. The study is being done to determine if NEXAGON plus compression bandaging is more effective that placebo plus compression bandaging.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nexagon® Low Dose | Weekly, topical application of Nexagon® low dose used with compression dressings. |
| DRUG | Nexagon® High Dose | Weekly, topical application of Nexagon® high dose used with compression dressings. |
| DRUG | Nexagon® Vehicle | Weekly, topical application of Nexagon® Vehicle used with compression dressings. |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2012-12-01
- Completion
- 2013-03-01
- First posted
- 2010-09-13
- Last updated
- 2014-05-01
Locations
34 sites across 4 countries: United States, Australia, New Zealand, South Africa
Source: ClinicalTrials.gov record NCT01199588. Inclusion in this directory is not an endorsement.